Watchlist Price Alert

Acceleron Pharma Inc. (XLRN)

NASDAQ: XLRN · Real-Time Price · USD

178.75

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-166.03M	-124.86M	-118.87M	-108.45M	-57.01M
Depreciation & Amortization	3.85M	3.94M	3.75M	2.83M	1.68M
Stock-Based Compensation	30.24M	23M	24.57M	28.25M	18.56M
Other Working Capital	833.11M	416.54M	287.1M	268.5M	130.64M
Other Non-Cash Items	-414.94M	-125.32M	-22.75M	-137.21M	-42.11M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	416.56M	129.44M	18.6M	137.86M	34.2M
Operating Cash Flow	-130.33M	-93.8M	-94.71M	-76.73M	-44.7M
Capital Expenditures	-4.2M	-3.29M	-2.59M	-4.4M	-3.38M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-238.23M	-395.14M	-73.57M	-179.94M	-218.31M
Sales Maturities Of Investments	268.03M	327.13M	199.09M	119.97M	112.89M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	25.6M	-71.29M	122.93M	-64.37M	-108.81M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	538.01M	258.72M	16.15M	220.3M	146.67M
Financial Cash Flow	538.01M	258.72M	16.15M	220.3M	146.67M
Net Cash Flow	433.27M	93.63M	44.37M	79.2M	-6.83M
Free Cash Flow	-134.53M	-97.09M	-97.3M	-81.13M	-48.08M